Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Background: Cisplatin-based chemoradiotherapy (CRT) remains a standard treatment for patients (pts) with locally advanced head and neck squamous cell carcinomas (HNSCCs). However, use of cisplatin may cause oto- and nephrotoxicity which may compromise both treatment delivery and longterm quality of life.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
